# Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells

> **NCT05214014** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus** · enrollment: 30 (estimated)

## Conditions studied

- Systemic Sclerosis

## Interventions

- **BIOLOGICAL:** Autologous Regulatory Т-cells
- **OTHER:** Standard treatment according to the clinical protocols

## Key facts

- **NCT ID:** NCT05214014
- **Lead sponsor:** Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05214014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05214014, "Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05214014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*